Related Experiment Video
Updated: Jun 15, 2026

Semi-Automated Isolation of the Stromal Vascular Fraction from Murine White Adipose Tissue Using a Tissue Dissociator
Published on: May 19, 2023
Role of Receptor-Interacting Protein 140 in human fat cells
Niklas Mejhert1, Jurga Laurencikiene, Amanda T Pettersson
1Department of Medicine, Huddinge, Lipid Laboratory, NVS, Karolinska Institutet, SE- 141 86 Stockholm, Sweden. niklas.mejhert@ki.se.
Background:
Mice lacking Receptor-interacting protein 140 (RIP140) have reduced body fat which at least partly is mediated through increased lipid and glucose metabolism in adipose tissue. In humans, RIP140 is lower expressed in visceral white adipose tissue (WAT) of obese versus lean subjects. We investigated the role of RIP140 in human subcutaneous WAT, which is the major fat depot of the body.
Methods:
Messenger RNA levels of RIP140 were measured in samples of subcutaneous WAT from women with a wide variation in BMI and in different human WAT preparations. RIP140 mRNA was knocked down with siRNA in in vitro differentiated adipocytes and the impact on glucose transport and mRNA levels of target genes determined.
Results:
RIP140 mRNA levels in subcutaneous WAT were decreased among obese compared to lean women and increased by weight-loss, but did not associate with mitochondrial DNA copy number. RIP140 expression increased during adipocyte differentiation in vitro and was higher in isolated adipocytes compared to corresponding pieces of WAT. Knock down of RIP140 increased basal glucose transport and mRNA levels of glucose transporter 4 and uncoupling protein-1.
Conclusions:
Human RIP140 inhibits glucose uptake and the expression of genes promoting energy expenditure in the same fashion as the murine orthologue. Increased levels of human RIP140 in subcutaneous WAT of lean subjects may contribute to economize on energy stores. By contrast, the function and expression pattern does not support that RIP140 regulate human obesity.
Insights
Human Receptor-interacting protein 140 (RIP140) inhibits glucose uptake and energy expenditure genes. Lower RIP140 in obese individuals suggests it doesn't drive human obesity but may conserve energy in lean subjects.
Area of Science:
- Metabolism and Endocrinology
- Adipose Tissue Biology
Background:
- Receptor-interacting protein 140 (RIP140) deficiency in mice reduces body fat via enhanced adipose tissue metabolism.
- Human RIP140 expression is lower in visceral white adipose tissue (WAT) of obese individuals compared to lean ones.
- This study focuses on RIP140's role in human subcutaneous WAT, the body's primary fat depot.
Purpose of the Study:
- To investigate the role of RIP140 in human subcutaneous white adipose tissue (WAT).
- To determine RIP140's impact on glucose transport and energy expenditure gene expression in human adipocytes.
Main Methods:
- Quantified RIP140 mRNA levels in subcutaneous WAT from women across a range of BMIs.
- Utilized siRNA to knock down RIP140 in in vitro differentiated adipocytes.
- Assessed the effects of RIP140 knockdown on glucose transport and target gene expression.
Main Results:
- RIP140 mRNA levels were lower in subcutaneous WAT of obese women and increased with weight loss.
- RIP140 expression increased during in vitro adipocyte differentiation and was higher in isolated adipocytes.
- RIP140 knockdown enhanced basal glucose transport and increased mRNA levels of glucose transporter 4 and uncoupling protein-1.
Conclusions:
- Human RIP140 inhibits glucose uptake and energy expenditure gene expression, similar to its mouse counterpart.
- Elevated RIP140 in lean subcutaneous WAT may promote energy conservation.
- RIP140's expression pattern and function do not support its role in regulating human obesity.
More Related Videos
Related Concept Videos
Insulin: The Receptor and Signaling Pathways
Receptor-mediated Endocytosis
Transducer Mechanism: Nuclear Receptors
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
Regulation of the Unfolded Protein Response
Intracellular Hormone Receptors

